Metastasis: a therapeutic target for cancer
Top Cited Papers
- 5 February 2008
- journal article
- review article
- Published by Springer Nature in Nature Clinical Practice Oncology
- Vol. 5 (4) , 206-219
- https://doi.org/10.1038/ncponc1066
Abstract
Metastasis remains the major driver of mortality in patients with cancer. The similarities and differences between primary tumors and metastases are described, and pathways controlling the colonization of a distant organ and incorporation of anti-metastatic therapies into clinical testing are discussed. The authors emphasize that the time is ripe for metastasis and metastatic colonization to enter mainstream clinical development and testing. Metastasis remains the major driver of mortality in patients with cancer. Our growing body of knowledge regarding this process provides the basis for the development of molecularly targeted therapeutics aimed at the tumor cell or its interaction with the host microenvironment. Here we discuss the similarity and differences between primary tumors and metastases, pathways controlling the colonization of a distant organ, and incorporation of antimetastatic therapies into clinical testing.Keywords
This publication has 99 references indexed in Scilit:
- Blockade of Hedgehog Signaling Inhibits Pancreatic Cancer Invasion and Metastases: A New Paradigm for Combination Therapy in Solid CancersCancer Research, 2007
- Requirement of KISS1 Secretion for Multiple Organ Metastasis Suppression and Maintenance of Tumor DormancyJNCI Journal of the National Cancer Institute, 2007
- Combination angiostatic therapy completely inhibits ocular and tumor angiogenesisProceedings of the National Academy of Sciences, 2007
- Inhibition of Pulmonary and Skeletal Metastasis by a Transforming Growth Factor-β Type I Receptor Kinase InhibitorCancer Research, 2006
- Bone Sialoprotein Mediates the Tumor Cell–Targeted Prometastatic Activity of Transforming Growth Factor β in a Mouse Model of Breast CancerCancer Research, 2006
- Regulation of cancer cell migration and bone metastasis by RANKLNature, 2006
- Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast CancerNew England Journal of Medicine, 2005
- Mechanisms of Bone MetastasisNew England Journal of Medicine, 2004
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences, 2003
- Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppressionNature Medicine, 1995